Home › Funds › Te Ahumairangi Investment Management Ltd › DGX
Te Ahumairangi Investment Management Ltd position in DGX
QUEST DIAGNOSTICS INC · Health Care
Te Ahumairangi Investment Management Ltd reported holding 27,661 shares of DGX (QUEST DIAGNOSTICS INC) in its Q3 2026 13F filing — a position valued at US$6.4M, representing 0.96% of its reported portfolio and ranking #36 among its reported holdings. Te Ahumairangi Investment Management Ltd has disclosed DGX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Te Ahumairangi Investment Management Ltd's DGX position evolved
Te Ahumairangi Investment Management Ltd first disclosed a stake in DGX in Q3 2023 at 66,284 shares (US$8.1M). Across 13 filings, Te Ahumairangi Investment Management Ltd increased the stake 4 time(s), trimmed it 8 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 27,661 shares valued at US$6.4M — a reduction of -2,960 shares quarter over quarter.. Notable position changes include a 26% trim in Q4 2023 (shares fell 3% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 66.28K | $8.08M | New |
| Q4 2023 | 49.02K | $6.76M | Reduce |
| Q1 2024 | 57.12K | $7.60M | Add |
| Q2 2024 | 48.48K | $6.64M | Reduce |
| Q3 2024 | 50.00K | $7.72M | Add |
| Q4 2024 | 43.19K | $6.52M | Reduce |
| Q1 2025 | 39.05K | $6.61M | Reduce |
| Q2 2025 | 40.00K | $7.18M | Add |
| Q3 2025 | 38.46K | $7.33M | Reduce |
| Q4 2025 | 34.54K | $5.99M | Reduce |
| Q1 2026 | 30.22K | $5.92M | Reduce |
| Q2 2026 | 30.62K | $6.49M | Add |
| Q3 2026 | 27.66K | $6.45M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About DGX and 13F data
DGX (QUEST DIAGNOSTICS INC) is a Health Care company. 26 other funds we track also report a position in DGX — the largest reported positions include Boston Partners (US$1.08B), EdgePoint Investment Group Inc. (US$476.4M), Grantham, Mayo, Van Otterloo & Co. LLC (US$449.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding DGX
- Boston Partners 4.64M sh · $1.08B · Q3 2026
- EdgePoint Investment Group Inc. 2.25M sh · $476.37M · Q2 2026
- Grantham, Mayo, Van Otterloo & Co. LLC 1.93M sh · $449.89M · Q3 2026
- DAVIS SELECTED ADVISERS 1.33M sh · $308.97M · Q3 2026
- M&G Plc 770.10K sh · $179.43M · Q3 2026
More on Te Ahumairangi Investment Management Ltd
FAQ
How long has Te Ahumairangi Investment Management Ltd held DGX?
Te Ahumairangi Investment Management Ltd has disclosed DGX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Te Ahumairangi Investment Management Ltd's current position in DGX?
As of Q3 2026, Te Ahumairangi Investment Management Ltd holds 27.66K shares of DGX (QUEST DIAGNOSTICS INC), valued at $6.45M, representing 0.96% of its reported portfolio and ranking #36.
Has Te Ahumairangi Investment Management Ltd been buying or selling DGX?
In the latest 13F filing (Q3 2026), Te Ahumairangi Investment Management Ltd reduced its position in DGX.
Which other funds hold DGX?
Other major institutional holders of DGX include Boston Partners, EdgePoint Investment Group Inc., Grantham, Mayo, Van Otterloo & Co. LLC, among 26 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.